Pain in the upper trapezius muscle. Chronic pain syndrome
Conditions
Interventions
Intervention 1: Intervention group: In addition to standard and routine treatment, the patient receives 4 subcutaneous injection sessions (including 20 mg of piroxicam in a volume of 1 ml + 1 ml of 2%
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Visual analog scale greater than 5 Pain duration greater than two months Patients who have received standard treatment and have not improved after one month Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: History of cervical spine fracture and spine-related problems Neck surgery, myelopathy or cervical radiculopathy after patient examination Patients with pain perception and recognition disorders Patients with known myopathy and polyneuropathy Mental illnesses or cognitive disorders Drug addiction Receiving narcotics and corticosteroids orally or intravenously in the last 6 months Pregnancy and blood clotting problems Patient's failure to return for follow-up Worsening or exacerbation of the patient's symptoms to the point where other treatment is required Patient's unwillingness to continue treatment or participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction in the patient. Timepoint: before the treatment, immediately after the treatment, one month and three months after the treatment in each of the two groups. Method of measurement: VAS pain scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParisa Taheri
Esfahan University of Medical Sciences
Outcome results
None listed